NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

COVID-19唾液篩查測試潛在全球市場:位置(旅遊站)、技術、模式(密集測試、分佈式測試)、區域市場規模、份額和趨勢分析、細分市場預測(2021年)~2023年)

COVID-19 Saliva Screening Test Potential Market Size, Share & Trends Analysis Report By Location (Travel Stations), By Technology, By Mode (Centralized Testing, Decentralized Testing), By Region, And Segment Forecasts, 2021 - 2023

出版商 Grand View Research, Inc. 商品編碼 1013917
出版日期 內容資訊 英文 178 Pages
商品交期: 2-10個工作天內
價格
COVID-19唾液篩查測試潛在全球市場:位置(旅遊站)、技術、模式(密集測試、分佈式測試)、區域市場規模、份額和趨勢分析、細分市場預測(2021年)~2023年) COVID-19 Saliva Screening Test Potential Market Size, Share & Trends Analysis Report By Location (Travel Stations), By Technology, By Mode (Centralized Testing, Decentralized Testing), By Region, And Segment Forecasts, 2021 - 2023
出版日期: 2021年06月02日內容資訊: 英文 178 Pages
簡介

全球 COVID-19 唾液篩查測試潛在市場規模預計從 2021 年到 2023 年以 4.8% 的複合年增長率增長,到 2023 年達到 34,062 億美元。我是。

對快速高效的唾液篩查測試潛力不斷增長的需求對市場增長產生了積極影響。

這主要是由於基於唾液的測試提供的各種好處、增加的產品監管批准以及向床旁檢測的範式轉變。螢光標記抗原/抗體測試是市場上最新的基於唾液的 COVID-19 篩查測試潛力之一,基於螢光檢測、生物化學、機器人自動化和雲計算的原理。

本報告調查和分析了全球 COVID-19 唾液篩查測試潛在市場,並提供了有關市場和行業前景、細分和區域前景以及競爭狀況的系統信息。我會的。

目錄

第一章調查方法和範圍

第 2 章執行摘要

第 3 章 COVID-19 唾液篩查測試潛在市場:行業展望

  • 螢光標記抗原/抗體測試:機會分析
    • 競品分析
  • 市場動態
    • 市場增長因素分析
    • 市場約束分析
    • 市場機會分析
    • 市場問題分析
  • 對比分析
    • 唾液檢測和基於棉籤的 RT-PCR 檢測
    • 唾液檢測和其他抗原檢測
  • 競爭分析
    • 重大交易及戰略聯盟分析
    • 戰略框架
    • 進入市場的公司分類
    • 產品批准/EUA 批准和發佈時間表

第 4 章按位置(美國/加拿大)劃分的市場估計和趨勢分析

  • 旅行站
  • 體育館
  • 音樂廳
  • 購物中心/中心
  • 遊樂園
  • 企業校園環境
  • 大學/學院
  • 工廠

第 5 章按位置(其他地區)劃分的市場估計和趨勢分析

  • 旅行站
  • 體育館
  • 娛樂場所
  • 企業環境
  • 大學/學院
  • 工廠

第 6 章市場估計和技術趨勢分析

  • 技術市場趨勢分析
  • 螢光標記抗原/抗體測試
    • 概述
    • 重大戰略舉措
  • RT-PCR
    • 技術觀點
    • 未來潛力
    • 商業視角
  • CRISPR-Cas9
    • 技術觀點
    • 未來潛力
    • 商業視角

第 7 章按模式劃分的市場估計和趨勢分析

  • 按模式分析市場趨勢
  • 密集考試(實驗室、醫院、診所)
  • 分佈式測試(移動測試、家庭測試等)

第8章按地區劃分的業務分析

  • 2020 年和 2023 年區域市場趨勢分析
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第九章公司簡介

  • 公司簡介
目錄
Product Code: GVR-4-68038-263-1

COVID-19 Saliva Screening Test Potential Market Growth & Trends

The global COVID-19 saliva screening test potential market size is expected to reach USD 3,406.2 billion by 2023, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 4.8% from 2021 to 2023. The rise in demand for rapid, efficient, saliva-based screening tests has positively impacted market growth.

This is primarily due to the various advantages offered by saliva-based tests, increasing product approvals by regulatory bodies, and a paradigm shift toward point-of-care testing. The fluorescence-labeled antigen/antibodies test is one of the recent saliva-based COVID-19 screening tests in the market which is based on the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.

As the number of people visiting public places is increasing and reaching pre-pandemic statistics in a few countries, there is a growing demand for rapid, point-of-care COVID-19 tests to mitigate viral transmission from asymptomatic people. This has enhanced the R&D for the development of simple yet effective saliva-based tests and is expected to create lucrative opportunities for several developers.

COVID-19 Saliva Screening Test Potential Market Report Highlights

The market estimates represent a potential market size for the COVID-19 saliva screening test based on the assumptions that the end-use locations have a 60% population attendance or capacity (60% of pre-COVID attendance) and the testing rate using test device is 100%

Saliva-based tests play a vital role in screening asymptomatic individuals thereby aiding in market revenue generation in the near future

The fluorescence-labeled antigen/antibodies test is designed to accelerate rapid point-of-access testing of individuals

Owing to the pandemic, the economy across the various sectors is severely impacted.

However, with the reopening of various sectors and locations such as shopping malls and amusement parks, there is a growing need for screening individuals to curb viral transmission

In the U.S., more than 40 amusement parks have prepared to reopen by the spring of 2021, thus increasing the demand for rapid tests

Thus, there is a high growth potential for the market with the increase in usage of the medical test at various locations to screen individuals

Regulatory bodies such as the U.S. FDA and European Medicine Agency (EMA) have supported these products by providing EUA and product approvals

In April 2021, Vatic Health received the CE mark for its on-the-spot' saliva antigen test for the SARS-CoV-2 virus. The test has also completed the Medicines and Healthcare Products Regulatory Agency (MHRA) registration in the U.K.

North America dominated the market owing to the high penetration and adoption of saliva-based screening tests in the region

The U.S. is the major contributor to revenue generation due to the emergence of new small and mid-sized companies engaged in the development of such tests

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
      • 1.3.3.1 List of secondary data sources
    • 1.3.4 Primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Market Model
  • 1.7 Model Details
    • 1.7.1 Location scope
      • 1.7.1.1 Travel stations
      • 1.7.1.1.1 Airports
      • 1.7.1.1.2 Ports & Cruise
      • 1.7.1.1.3 Train Stations
      • 1.7.1.1.4 Border crossings
      • 1.7.1.2 Sports arenas
      • 1.7.1.3 Entertainment venues
      • 1.7.1.4 Universities & Colleges
      • 1.7.1.5 Corporate Campus Environments and Factories
    • 1.7.2 Technology scope
      • 1.7.2.1 FDA recommendations for the use of diagnostic tests for screening
    • 1.7.3 Region-wise market: Base estimates
  • 1.8 Objectives
    • 1.8.1 Objective 1:
    • 1.8.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Market Summary

Chapter 3 COVID-19 Saliva Screening Test Potential Market: Industry Outlook

  • 3.1 Fluorescence-labeled antigen/antibodies testing: Opportunity Analysis
    • 3.1.1 Competitive products analysis
      • 3.1.1.1 Competitive analysis- COVID-19 POC testing
  • 3.2 Market Dynamics
    • 3.2.1 Market driver analysis
      • 3.2.1.1 Advantages of using saliva as a diagnostic specimen
      • 3.2.1.2 Increasing product approvals by regulatory agencies
      • 3.2.1.3 Paradigm shift toward point-of-care testing
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 High penetration of swab-based testing methods
      • 3.2.2.2 Limitations related to the methodological approach
    • 3.2.3 Market opportunity analysis
      • 3.2.3.1 Safe, quick, and economical nature of saliva-based COVID-19 tests
    • 3.2.4 Market challenge analysis
      • 3.2.4.1 Challenges pertaining to COVID-19 testing in healthcare settings
  • 3.3 Comparative Analysis
    • 3.3.1 Saliva testing versus swab-based RT-PCR testing
      • 3.3.1.1 Global swab-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
    • 3.3.2 Saliva testing versus other antigen testing
  • 3.4 Competitive Analysis
    • 3.4.1 Major deals &strategic alliances analysis
      • 3.4.1.1 Technology collaboration & licensing partnership
      • 3.4.1.2 Distribution partnership
    • 3.4.2 Strategy framework
    • 3.4.3 Company participant categorization
    • 3.4.4 Product approval/EUA authorizations& launch timeline

Chapter 4 COVID-19 Saliva Screening Test Potential Market: Location Estimates & Trend Analysis (U.S. & Canada)

  • 4.1 Travel Stations
    • 4.1.1 Airports
    • 4.1.2 Cruise
    • 4.1.3 Port
    • 4.1.4 Train stations
    • 4.1.5 Border crossing
  • 4.2 Sports Arenas
  • 4.3 Concert Halls
  • 4.4 Shopping Malls and Centers
  • 4.5 Amusement Parks
  • 4.6 Corporate Campus Environment
  • 4.7 Universities and Colleges
  • 4.8 Factories
    • 4.8.1 Food processing plants
    • 4.8.2 Meat packing plants
    • 4.8.3 Pharmaceutical plants
    • 4.8.4 Mining
    • 4.8.5 Retail working warehouses

Chapter 5 COVID-19 Saliva Screening Test Potential Market: Location Estimates & Trend Analysis (Other Regions)

  • 5.1 Travel Stations
  • 5.2 Sport Arenas
  • 5.3 Entertainment Venues
  • 5.4 Corporate Environments
  • 5.5 Universities & Colleges
  • 5.6 Factories

Chapter 6 COVID-19 Saliva Screening Test Potential Market: Technology Estimates & Trend Analysis

  • 6.1 COVID-19 Saliva Screening Market: Technology Movement Analysis
  • 6.2 Fluorescence-labeled antigen/antibodies testing
    • 6.2.1 Overview
    • 6.2.2 Key strategic intiatives
  • 6.3 RT-PCR
    • 6.3.1 Technical viewpoint
    • 6.3.2 Future potential
    • 6.3.3 Commercial viewpoint
  • 6.4 CRISPR-Cas9
    • 6.4.1 Technical viewpoint
    • 6.4.2 Future potential
    • 6.4.3 Commercial viewpoint

Chapter 7 COVID-19 Saliva Screening Test Potential Market: Mode Estimates & Trend Analysis

  • 7.1 COVID-19 Saliva Screening Test Potential Market: Mode Movement Analysis
  • 7.2 Centralized Testing (Labs, Hospitals, Clinics)
  • 7.3 Decentralized Testing (Mobile Testing, At-home Testing, Others)

Chapter 8 Regional Business Analysis

  • 8.1 COVID-19 Saliva Screening Test Potential Market: Regional Movement Analysis, 2020 & 2023
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
  • 8.4 Asia Pacific
  • 8.5 Rest of the World

Chapter 9 Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 ARUP Laboratories.
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
      • 9.1.1.4 Strategic initiatives
    • 9.1.2 Vatic Health
      • 9.1.2.1 Company overview
      • 9.1.2.2 Product benchmarking
      • 9.1.2.3 Strategic initiatives
    • 9.1.3 MOgene
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 Psomagen, INC.
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 DXTERITY Diagnostics, INC.
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 KONICA MINOLTA, INC.
      • 9.1.6.1 Company overview
      • 9.1.6.2 Ambry Genetics
      • 9.1.6.2.1 Company overview
      • 9.1.6.3 Financial performance
      • 9.1.6.3.1 Financial performance
      • 9.1.6.4 Product benchmarking
      • 9.1.6.5 Strategic initiatives
    • 9.1.7 Fluidigm Corporation
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial performance
      • 9.1.7.3 Product benchmarking
      • 9.1.7.4 Strategic initiatives
    • 9.1.8 Phosphorus Diagnostics LLC
      • 9.1.8.1 Company overview
      • 9.1.8.2 Product benchmarking
      • 9.1.8.3 Strategic initiatives
    • 9.1.9 Gravity Diagnostics
      • 9.1.9.1 Company overview
      • 9.1.9.2 Product benchmarking
      • 9.1.9.3 Strategic initiatives
    • 9.1.10 OraSure Technologies
      • 9.1.10.1 Company overview
      • 9.1.10.2 DNA Genotek, Inc.
      • 9.1.10.2.1 Company overview
      • 9.1.10.3 Financial performance
      • 9.1.10.3.1 Financial performance
      • 9.1.10.4 Product benchmarking
      • 9.1.10.5 Strategic initiatives
    • 9.1.11 Quidel Corporation
      • 9.1.11.1 Company overview
      • 9.1.11.2 Financial performance
      • 9.1.11.3 Product benchmarking
      • 9.1.11.4 Strategic initiatives
    • 9.1.12 ABBOTT
      • 9.1.12.1 Company overview
      • 9.1.12.2 Financial performance
      • 9.1.12.3 Product benchmarking
      • 9.1.12.4 Strategic initiatives
    • 9.1.13 LumiraDX
      • 9.1.13.1 Company overview
      • 9.1.13.2 Financial performance
      • 9.1.13.3 Product benchmarking
      • 9.1.13.4 Strategic initiatives
    • 9.1.14 FluroTech Ltd.
      • 9.1.14.1 Company overview
      • 9.1.14.2 Financial performance
      • 9.1.14.3 Product benchmarking
      • 9.1.14.4 Strategic initiatives

List of Tables

  • Table 1 Scenarios considered for the 2020 potential market of Fluorescence-labeled antigen/antibodies testing in the U.S. and Canada
  • Table 2 Amusement and water parks in the U.S.
  • Table 3 Food & beverage manufacturing establishments in the U.S.
  • Table 4 Potential market share, by technology (Scenario C), 2020 (%)
  • Table 5 Competitive products analysis
  • Table 6 Competitive Analysis- COVID-19 POC Testing
  • Table 7 Saliva-based COVID testing product approval & timeline
  • Table 8 A list of Canadian universities and colleges
  • Table 9 Summary of studies pertaining to COVID-19 detection using CRISPR technology
  • Table 10 North America COVID-19 saliva screening test potential market estimates & forecast, by location, 2020 - 2023 (USD Million)
  • Table 11 North America COVID-19 saliva screening test potential market estimates & forecast, by travel stations, 2020 - 2023 (USD Million)
  • Table 12 North America COVID-19 saliva screening test potential market estimates & forecast, by factories, 2020 - 2023 (USD Million)
  • Table 13 North America COVID-19 saliva screening test potential market estimates & forecast, by technology, 2020 - 2023 (USD Million)
  • Table 14 North America COVID-19 saliva screening test potential market estimates & forecast, by mode, 2020 - 2023 (USD Million)
  • Table 15 U.S. COVID-19 saliva screening test potential market estimates & forecast, by location, 2020 - 2023 (USD Million)
  • Table 16 U.S. COVID-19 saliva screening test potential market estimates & forecast, by travel stations, 2020 - 2023 (USD Million)
  • Table 17 U.S. COVID-19 saliva screening test potential market estimates & forecast, by factories, 2020 - 2023 (USD Million)
  • Table 18 U.S. COVID-19 saliva screening test potential market estimates & forecast, by technology, 2020 - 2023 (USD Million)
  • Table 19 U.S. COVID-19 saliva screening test potential market estimates & forecast, by mode, 2020 - 2023 (USD Million)
  • Table 20 Canada COVID-19 saliva screening test potential market estimates & forecast, by location, 2020 - 2023 (USD Million)
  • Table 21 Canada COVID-19 saliva screening test potential market estimates & forecast, by travel stations, 2020 - 2023 (USD Million)
  • Table 22 Canada COVID-19 saliva screening test potential market estimates & forecast, by factories, 2020 - 2023 (USD Million)
  • Table 23 Canada COVID-19 saliva screening test potential market estimates & forecast, by technology, 2020 - 2023 (USD Million)
  • Table 24 Canada COVID-19 saliva screening test potential market estimates & forecast, by mode, 2020 - 2023 (USD Million)
  • Table 25 Europe COVID-19 saliva screening test potential market estimates & forecast, by location, 2020 - 2023 (USD Million)
  • Table 26 Europe COVID-19 saliva screening test potential market estimates & forecast, by technology, 2020 - 2023 (USD Million)
  • Table 27 Europe COVID-19 saliva screening test potential market estimates & forecast, by mode, 2020 - 2023 (USD Million)
  • Table 28 Asia Pacific COVID-19 saliva screening test potential market estimates & forecast, by location, 2020 - 2023 (USD Million)
  • Table 29 Asia Pacific COVID-19 saliva screening test potential market estimates & forecast, by technology, 2020 - 2023 (USD Million)
  • Table 30 Asia Pacific. COVID-19 saliva screening test potential market estimates & forecast, by mode, 2020 - 2023 (USD Million)
  • Table 31 Rest of World COVID-19 saliva screening test potential market estimates & forecast, by location, 2020 - 2023 (USD Million)
  • Table 32 Rest of World COVID-19 saliva screening test potential market estimates & forecast, by technology, 2020 - 2023 (USD Million)
  • Table 33 Rest of World COVID-19 saliva screening test potential market estimates & forecast, by mode, 2020 - 2023 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Model details
  • Fig. 9 Top 10 U.S. Airlines, by Domestic Scheduled Enplanements, 2019 vs. 2020
  • Fig. 10 Weekly container ship port calls, Global, 2019 vs. 2020
  • Fig. 11 Impact of COVID-19 on international passenger traffic (all locations)
  • Fig. 12 Impact of COVID-19 on domestic passenger traffic (all locations)
  • Fig. 13 Passenger entries, exits, &interchanges at key railway stations in Great Britain, 2020 (% change from 2019)
  • Fig. 14 NFL games, 2020: Statistics
  • Fig. 15 Number of shopping malls & centers in North America, by region
  • Fig. 16 Number stores in shopping malls & centers in North America, by store type
  • Fig. 17 Operational mode of major universities & colleges in the U.S. (Post-COVID)
  • Fig. 18 Laboratory-confirmed COVID-19 cases among workers in meat and poultry processing facilities and food manufacturing and agriculture workplaces in the U.S.
  • Fig. 19 Preparedness of the food & beverage industry against COVID-19
  • Fig. 20 Market Segmentation
  • Fig. 21 Scenario A: Potential Market Size for Fluorescence-labeled antigen/antibodies testing, North America, 2020 (USD Million)
  • Fig. 22 Scenario B: Potential Market Size for Fluorescence-labeled antigen/antibodies testing, North America, 2020 (USD Million)
  • Fig. 23 Scenario C: Potential Market Size for Fluorescence-labeled antigen/antibodies testing, North America, 2020 (USD Million)
  • Fig. 24 Market driver relevance analysis (Current & future impact)
  • Fig. 25 Advantages of using saliva as a diagnostic specimen
  • Fig. 26 Market restraint relevance analysis (Current & future impact)
  • Fig. 27 Validated sample types for COVID-19 testing
  • Fig. 28 Global swab-based COVID-19 diagnostics market, 2020 - 2027 (USD million)
  • Fig. 29 Currently available test format for COVID-19 testing
  • Fig. 30 Currently available assay target for COVID-19 testing
  • Fig. 31 Strategy framework
  • Fig. 32 Company participant categorization
  • Fig. 33 Number of U.S. airports analyzed, by state
  • Fig. 34 COVID-19 saliva screening potential market (U.S. & Canada): Location movement analysis
  • Fig. 35 Domestic and international airline travel on the U.S. and foreign airlines
  • Fig. 36 World passenger traffic evolution at times of crisis/disease outbreak
  • Fig. 37 Total system (domestic and international) scheduled enplanements on the U.S. and foreign airlines
  • Fig. 38 Top 10 U.S. Airports, ranked by 2020 Domestic Scheduled Enplanements
  • Fig. 39 Canadian air passenger traffic from 2015 - 2019
  • Fig. 40 Alaska cruise statistics, 2016 - 2017
  • Fig. 41 Canada cruise industry, 2019
  • Fig. 42 Passenger Volume by Region 2019 (Tens of Thousands), 2019
  • Fig. 43 Value of U.S.-International Freight Flow Transported by Vessel: January 2019-October 2020 in billion
  • Fig. 44 Rail passenger traffic in the U.S. (2006 - 2019) (in billion passenger-kilometers)
  • Fig. 45 The list of American and Canadian football leagues.
  • Fig. 46 Change from pre-pandemic habits to planned post-pandemic habits in Canadian shoppers
  • Fig. 47 Mall traffic in 2020 in the U.S.
  • Fig. 48 America's Most-Visited Shopping Malls, 2011
  • Fig. 49 Theme park reopening in the U.S.
  • Fig. 50 Amusement park reopening models
  • Fig. 51 California state restrictions
  • Fig. 52 Steps taken by companies to tackle COVID-19 challenges
  • Fig. 53 Industry preparedness survey
  • Fig. 54 The U.S. meat and poultry industry, 2017 (USD million)
  • Fig. 55 The employment growth for pharmaceutical and medicine manufacturing from 2008 - 2020
  • Fig. 56 The number of employees in the U.S. biopharmaceutical industry by subsector in 2017
  • Fig. 57 Top 10 US-based mining companies as of July 2020
  • Fig. 58 COVID-19 impact on mining and metal companies
  • Fig. 59 Employment growth rate for Warehousing and Storage, 2008 - 2020
  • Fig. 60 Total number of warehouses in the U.S. from 2007 - 2019
  • Fig. 61 Top 20 warehouses in North America as of 2018
  • Fig. 62 COVID-19 saliva screening potential market (Other regions): Location outlook key takeaways
  • Fig. 63 COVID-19 saliva screening potential market (Other regions): Location movement analysis
  • Fig. 64 Number of international passengers, by region in million
  • Fig. 65 Busiest railway stations in Asia and Europe
  • Fig. 66 COVID-19 impact on Cruise community
  • Fig. 67 Top theme parks (other regions) by value and attendance
  • Fig. 68 Average number of visitors in shopping malls in Italy in 2016 in million
  • Fig. 69 Measures Taken By U.K. Universities Against COVID-19
  • Fig. 70 Student numbers in the U.K.'s higher education (2018 - 19)
  • Fig. 71 COVID-19 saliva screening market: Technology outlook key takeaways
  • Fig. 72 COVID-19 saliva screening market: Technology movement analysis
  • Fig. 73 Feluda COVID-19 test kit
  • Fig. 74 Sherlock-based COVID-19 test
  • Fig. 75 COVID-19 saliva screening test potential market: Mode outlook key takeaways
  • Fig. 76 COVID-19 saliva screening test potential market: Mode movement analysis
  • Fig. 77 Impact of COVID-19 on passenger traffic and aviation revenue in 2020, by region (as compared to 2019)
  • Fig. 78 COVID-19 saliva screening test potential market: Regional movement analysis